MiTest Health

MiTest Health, LLC is a biotechnology company dedicated to creating computer-based tools for predicting the prognosis of patients with chronic diseases. By integrating clinical data, serological and genetic markers, domain expertise, and advanced statistical techniques, computer models have been developed to display expected disease outcomes for both patients and providers to facilitate shared decision-making. The first product from MiTest Health is a personalized risk and outcome prediction tool for Crohn's disease; additional models for inflammatory bowel disease and other disease states are currently under development.